These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 15297377)

  • 21. Urokinase plasminogen activator receptor promotes macrophage infiltration into the vascular wall of ApoE deficient mice.
    Gu JM; Johns A; Morser J; Dole WP; Greaves DR; Deng GG
    J Cell Physiol; 2005 Jul; 204(1):73-82. PubMed ID: 15573379
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extracellular matrix metalloproteinase inducer up-regulates the urokinase-type plasminogen activator system promoting tumor cell invasion.
    Quemener C; Gabison EE; Naïmi B; Lescaille G; Bougatef F; Podgorniak MP; Labarchède G; Lebbé C; Calvo F; Menashi S; Mourah S
    Cancer Res; 2007 Jan; 67(1):9-15. PubMed ID: 17210677
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeted deletion of class A macrophage scavenger receptor increases the risk of cardiac rupture after experimental myocardial infarction.
    Tsujita K; Kaikita K; Hayasaki T; Honda T; Kobayashi H; Sakashita N; Suzuki H; Kodama T; Ogawa H; Takeya M
    Circulation; 2007 Apr; 115(14):1904-11. PubMed ID: 17389263
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of the plasminogen-plasmin system on hypertensive renal and cardiac damage.
    Knier B; Cordasic N; Klanke B; Heusinger-Ribeiro J; Daniel C; Veelken R; Hartner A; Hilgers KF
    J Hypertens; 2011 Aug; 29(8):1602-12. PubMed ID: 21610512
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative RT-PCR assays for the determination of urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 mRNA in primary tumor tissue of breast cancer patients: comparison to antigen quantification by ELISA.
    Biermann JC; Holzscheiter L; Kotzsch M; Luther T; Kiechle-Bahat M; Sweep FC; Span PN; Schmitt M; Magdolen V
    Int J Mol Med; 2008 Feb; 21(2):251-9. PubMed ID: 18204793
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpression of urokinase by plaque macrophages causes histological features of plaque rupture and increases vascular matrix metalloproteinase activity in aged apolipoprotein e-null mice.
    Hu JH; Du L; Chu T; Otsuka G; Dronadula N; Jaffe M; Gill SE; Parks WC; Dichek DA
    Circulation; 2010 Apr; 121(14):1637-44. PubMed ID: 20351234
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased plasminogen activator inhibitor type-1 (PAI-1) in the heart as a function of age.
    Sobel BE; Lee YH; Pratley RE; Schneider DJ
    Life Sci; 2006 Sep; 79(17):1600-5. PubMed ID: 16750223
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The plasma levels of transforming growth factor beta1 and the protein expressions of alpha-SMA, urokinase plasminogen activator and plasminogen activator inhibitor-1 in liver of patients with different grades of hepatic fibrosis].
    Wu XR; Lv MH; Wang Q; Shi SS; Guo WD
    Zhonghua Gan Zang Bing Za Zhi; 2004 Jul; 12(7):400-2. PubMed ID: 15268802
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fracture healing in mice deficient in plasminogen activator inhibitor-1.
    Rundle CH; Wang X; Wergedal JE; Mohan S; Lau KH
    Calcif Tissue Int; 2008 Oct; 83(4):276-84. PubMed ID: 18820962
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urokinase-type plasminogen activator plays a critical role in angiotensin II-induced abdominal aortic aneurysm.
    Deng GG; Martin-McNulty B; Sukovich DA; Freay A; Halks-Miller M; Thinnes T; Loskutoff DJ; Carmeliet P; Dole WP; Wang YX
    Circ Res; 2003 Mar; 92(5):510-7. PubMed ID: 12600880
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transplantation of urokinase-type plasminogen activator gene-modified bone marrow-derived liver stem cells reduces liver fibrosis in rats.
    Sun C; Li DG; Chen YW; Chen YW; Wang BC; Sun QL; Lu HM
    J Gene Med; 2008 Aug; 10(8):855-66. PubMed ID: 18481824
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Urokinase-type plasminogen activator receptor regulates leukocyte recruitment during experimental pneumococcal meningitis.
    Paul R; Winkler F; Bayerlein I; Popp B; Pfister HW; Koedel U
    J Infect Dis; 2005 Mar; 191(5):776-82. PubMed ID: 15688295
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Urokinase plasminogen activator is a central regulator of macrophage three-dimensional invasion, matrix degradation, and adhesion.
    Fleetwood AJ; Achuthan A; Schultz H; Nansen A; Almholt K; Usher P; Hamilton JA
    J Immunol; 2014 Apr; 192(8):3540-7. PubMed ID: 24616477
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasminogen activator inhibitor-1 deficiency enhances flow-induced smooth muscle cell migration.
    Cullen JP; Nicholl SM; Sayeed S; Sitzmann JV; Okada SS; Cahill PA; Redmond EM
    Thromb Res; 2004; 114(1):57-65. PubMed ID: 15262486
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Macrophage apolipoprotein E reduces atherosclerosis and prevents premature death in apolipoprotein E and scavenger receptor-class BI double-knockout mice.
    Yu H; Zhang W; Yancey PG; Koury MJ; Zhang Y; Fazio S; Linton MF
    Arterioscler Thromb Vasc Biol; 2006 Jan; 26(1):150-6. PubMed ID: 16269665
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The plasminogen-MMP system is more activated in the scar than in viable myocardium 3 months post-MI in the rat.
    Gaertner R; Jacob MP; Prunier F; Angles-Cano E; Mercadier JJ; Michel JB
    J Mol Cell Cardiol; 2005 Jan; 38(1):193-204. PubMed ID: 15623436
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasminogen activator inhibitor-1 potentiates LPS-induced neutrophil activation through a JNK-mediated pathway.
    Kwak SH; Wang XQ; He Q; Fang WF; Mitra S; Bdeir K; Ploplis VA; Xu Z; Idell S; Cines D; Abraham E
    Thromb Haemost; 2006 May; 95(5):829-35. PubMed ID: 16676075
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasminogen activator inhibitor-1 modulates adipocyte differentiation.
    Liang X; Kanjanabuch T; Mao SL; Hao CM; Tang YW; Declerck PJ; Hasty AH; Wasserman DH; Fogo AB; Ma LJ
    Am J Physiol Endocrinol Metab; 2006 Jan; 290(1):E103-E113. PubMed ID: 16144810
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasminogen Activator Inhibitor-1 Protects Mice Against Cardiac Fibrosis by Inhibiting Urokinase-type Plasminogen Activator-mediated Plasminogen Activation.
    Gupta KK; Donahue DL; Sandoval-Cooper MJ; Castellino FJ; Ploplis VA
    Sci Rep; 2017 Mar; 7(1):365. PubMed ID: 28336948
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insulin resistance increases PAI-1 in the heart.
    Sobel BE; Schneider DJ; Lee YH; Pratley RE
    Biochem Biophys Res Commun; 2006 Jul; 346(1):102-7. PubMed ID: 16750510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.